B
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K542.0 KBBIORA THERAPEUTICS, INC.Dec 30, 8:07 AM ET·0001213900-24-113256
- 8-K168.9 KBBIORA THERAPEUTICS, INC.Dec 10, 7:00 AM ET·0000950170-24-134755
- 10-Q11.2 MBBIORA THERAPEUTICS, INC.Nov 14, 4:10 PM ET·0000950170-24-127060
- 8-K463.7 KBBIORA THERAPEUTICS, INC.Nov 14, 4:05 PM ET·0000950170-24-127030
- SC 13G52.7 KBBIORA THERAPEUTICS, INC.Nov 14, 10:01 AM ET·0000902664-24-006541
- 8-K572.0 KBBIORA THERAPEUTICS, INC.Oct 29, 4:43 PM ET·0001193125-24-246602
- 8-K218.9 KBBIORA THERAPEUTICS, INC.Oct 11, 8:00 AM ET·0000950170-24-114214
- SC 13D/A254.5 KBBIORA THERAPEUTICS, INC.Oct 9, 5:40 PM ET·0001193125-24-235295
- 8-K186.9 KBBIORA THERAPEUTICS, INC.Oct 7, 4:45 PM ET·0000950170-24-113271
- 8-K186.3 KBBIORA THERAPEUTICS, INC.Sep 13, 4:05 PM ET·0000950170-24-106347
Insiders
10- Alter Jeffrey D.Director
- Athyrium Capital Management, LP10% Owner
- Athyrium Opportunities Fund (A) LP10% Owner
- Athyrium Opportunities Fund (B) LP10% Owner
- Athyrium Opportunities III Co-Invest 1 LP10% Owner
- Bigalke John T.Director
- Cooper Matthew TChief Scientific Officer
- dEsparbes EricChief Financial Officer
- Ferrell JeffreyDirector, 10% Owner
- Gianakopoulos GeorgeSenior Vice President of Sales
Tickers
No tickers on record
Addresses
business
4330 LA JOLLA VILLAGE DRIVE SUITE 200
SAN DIEGO, CA, 92122
mailing
4330 LA JOLLA VILLAGE DRIVE SUITE 200
SAN DIEGO, CA, 92122
Former Names
- PROGENITY, INC.2022-04-19
- ASCENDANT MDX, INC.2013-06-28